Bloomage Biotechnology Hits Day Low at CNY 33.15 Amid Price Pressure

Bloomage Biotechnology Corp. has experienced a notable decline today, with the stock dropping by 3.9% and reaching an intraday low of CNY 33.15. This performance stands in contrast to the China Shanghai Composite, which has decreased by 1.7% on the same day. Over the past week, Bloomage has seen a more significant downturn, with a 9.78% drop, and its one-month performance reflects a substantial decline of 19.99%. The company's long-term growth trajectory appears concerning, as it has reported negative results for the last eight consecutive quarters. Key financial metrics indicate challenges, including a net profit of CNY 251.56 million, which has decreased by 30.51%. Additionally, the operating cash flow has reached a low of CNY 605.2 million, and the inventory turnover ratio stands at just 1.18 times. With a market capitalization of CNY 16,122 million, Bloomage Biotechnology operates within the specialty chemicals industry. The stock's return on equity is currently at 1.72%, and it has consistently underperformed against the benchmark over the last three years, reflecting a broader trend of declining profitability and market position.